Recent advancements in single-cell multi-omics technologies have provided unprecedented insights into the cellular and molecular heterogeneity of DS-associated hematologic neoplasms.Hematologic Neoplasms Associated with Down Syndrome Cellular and Molecular Heterogeneity of the DiseasesSource: Peroni et al.